We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
The Role of Mass Spectrometry in Hepatocellular Carcinoma Biomarker Discovery.
- Authors
Shen, Eric Yi-Liang; U, Mei Ran Abellona; Cox, I. Jane; Taylor-Robinson, Simon D.
- Abstract
Hepatocellular carcinoma (HCC) is the main liver malignancy and has a high mortality rate. The discovery of novel biomarkers for early diagnosis, prognosis, and stratification purposes has the potential to alleviate its disease burden. Mass spectrometry (MS) is one of the principal technologies used in metabolomics, with different experimental methods and machine types for different phases of the biomarker discovery process. Here, we review why MS applications are useful for liver cancer, explain the MS technique, and briefly summarise recent findings from metabolomic MS studies on HCC. We also discuss the current challenges and the direction for future research.
- Subjects
HEPATOCELLULAR carcinoma; MASS spectrometry; LIVER cancer; BIOMARKERS; DEATH rate
- Publication
Metabolites (2218-1989), 2023, Vol 13, Issue 10, p1059
- ISSN
2218-1989
- Publication type
Article
- DOI
10.3390/metabo13101059